Previous Article | Next Article ![]()
Journal of Clinical Microbiology, August 2008, p. 2652-2658, Vol. 46, No. 8
0095-1137/08/$08.00+0 doi:10.1128/JCM.00192-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333
Received 30 January 2008/ Returned for modification 13 April 2008/ Accepted 16 June 2008
|
|
|---|
|
|
|---|
Detection of most paramyxoviruses has been routinely carried out by cell culture isolation, electron microscopy, antigen detection assays (immunofluorescence assays or enzyme immunoassays [EIA]), serologic assays, and genome-based assays, such as PCR assays. Each system has limitations. Traditional genome-based, antigen-based, and antibody-based assays usually are too specific to detect novel viruses. Cell culture isolation will allow detection only of viruses that grow and replicate in the culture system used and will require further characterization, usually by antigen- or genome-based assays. Electron microscopy requires a fairly high titer of virus for visualization and also requires further characterization.
To increase our ability to detect novel viruses, we chose to develop broadly reactive PCR assays. This strategy has been used very successfully to identify and characterize a number of novel human viruses, including severe acute respiratory syndrome coronavirus (5), hepatitis G virus (17), Sin Nombre virus (8), human retrovirus 5 (3), and novel animal viruses, such as the macaque gammaherpesvirus (15) and pig endogenous retrovirus (9). The present article describes the development of a set of PCR assays that should detect all known and novel paramyxoviruses. The primers for these assays were developed from highly conserved regions of the genome. We applied the consensus-degenerate hybrid oligonucleotide primer methodology (13, 14) in primer design and seminested PCRs to optimize the specificity and sensitivity of these broadly reactive assays.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Reference viruses used in evaluating PCR in this work
|
RT-PCR and nested RT-PCR amplification. To maximize sensitivity and specificity, we nested or seminested PCR assays and optimized reaction conditions, including primer concentration, magnesium (Mg2+) concentration, and thermal cycling temperatures and profiles. For the first PCR in the seminested assay, we used the SuperScript III One-Step reverse transcription-PCR (RT-PCR) kit (Invitrogen, Carlsbad, CA). The optimized PCR mixtures contained 50 pmol each of forward and reverse primers, 1x buffer with a final concentration of 2.0 mM MgSO4 and 200 µM (each) deoxynucleoside triphosphates, 20 U of RNase inhibitor, a 5-µl aliquot of RNA/DNA extracts, and 1 U of SuperScript III RT/Platinum Taq mix. Water was then added to achieve a final volume of 50 µl. The RT-PCR mixture was sequentially incubated at 60°C for 1 min for denaturing, 44 to 50°C for 30 min (for RT), 94°C for 2 min (for hot start), and then 40 cycles at 94°C for 15 s, 48 to 50°C for 30 s, 72°C for 30 s, and a final extension at 72°C for 7 min. For the second amplification in the seminested PCR assay, we used 1x buffer (Platinum Taq kit; Invitrogen), 2 mM MgCl2, 200 µM (each) of deoxynucleoside triphosphates, 50 pmol (each) of forward and reverse primers, 1 U Platinum Taq, one 2-µl aliquot from the first reaction, and water to achieve a final volume of 50 µl. The mixture was first heated to 94°C for 2 min. The cycling conditions were 40 cycles with the same conditions as for the first amplification: 94°C for 15 s, primer annealing at 48 to 50°C for 30 s, and 72°C for 30 s. A final extension was carried out at 72°C for 7 min. The final nested or seminested PCR products were visualized by UV light after electrophoresis on a 2% agarose gel containing 0.5 µg/ml ethidium bromide in 0.5x Tris-borate buffer (pH 8.0). A DNA VIII marker (Roche, Indianapolis, IN) was run in the gels to estimate amplicon size.
Specificity and sensitivity. Initial primer validation and selections were performed using one reference RNA template from the subfamily or genera for which the PCR assay was designed. Mumps virus RNA was used for the Rubulavirus-Avulavirus genus subgroup-specific primers and the Paramyxovirinae subfamily primers, Hendra RNA for the Morbillivirus-Respirovirus-Henipavirus genus subgroup-specific primers, and respiratory syncytial virus A RNA for the Pneumovirinae subfamily-specific primers. Following the initial screening, the selected primer pairs were then tested against the representative paramyxoviruses listed in Table 1. Finally, to test for unanticipated nonspecific reactivity, the PCR assays were tested against pooled nucleic acids of influenza A and B viruses, rhinoviruses, adenovirus, two distinct human coronaviruses, human coronavirus 229E, and human coronavirus OC-43 and bacteria (Chlamydia pneumoniae, Haemophilus influenzae, Streptococcus pneumoniae, and Mycoplasma pneumoniae).
The sensitivities of the PCR assays were determined using two sources of RNA: RNA that was extracted from each dilution of a 10-fold dilution series of virus-infected cell culture with known infectivity titers (PFU) and serial dilutions of synthetic RNA that was transcribed in vitro from cloned genome fragments as previously described (18).
Sequencing. Amplicons from the final round of PCR were purified using the QIAquick PCR purification kit (Qiagen, Inc., Valencia, CA). Both strands of the amplicons were sequenced with a BigDye Terminators v1.1 ready reaction cycle sequencing kit on an ABI Prism 3100 automated sequencer (Applied Biosystems, Foster City, CA) using the corresponding PCR primers. The remaining reaction conditions were according to the manufacturer's instructions.
|
|
|---|
![]() View larger version (17K): [in a new window] |
FIG. 1. Similarity plots of the aligned paramyxoviruses' genomes. The plots were obtained using an in-house program based on multiple alignments of viral genomes from 29 different strains in the Paramyxoviridae (A), 22 different strains in the Paramyxovirinae (B), and 7 different strains in the Pneumovirinae (C). The identity percentage score given on the y axis was calculated based on the exact-match percentage with a window of 25 nucleotide positions, and the window was progressively moved across the alignment in 1-nucleotide-position steps. The x axis shows the first position of the window in the multiple alignments of the viral genomes.
|
|
View this table: [in a new window] |
TABLE 2. Consensus degenerate primers used for detection of paramyxoviruses
|
Broad reactivity of consensus degenerate primers. As shown in Fig. 2A and B, all of the 25 reference viruses representing five genera from the Paramyxovirinae subfamily were successfully detected by pan-Paramyxovirinae primers. As shown in Fig. 3 and 4, members of the two groups of genera within this subfamily were also detected by the appropriate subgroup-specific primers. The observed variation in amplicon intensity was probably due at least in part to differences in amount of template RNA for the respective viruses. No amplicons were detected for the PCR assays against the pooled "other respiratory pathogen genomes" or the negative controls (see Fig. 6). Two previously unclassified paramyxoviruses, FDLV and Salem virus (SalV), were amplified only by the Morbillivirus-Respirovirus-Henipavirus genus subgroup-specific primers and Menangle virus only by the Rubulavirus-Avulavirus genus subgroup-specific primers. These results suggest that FDLV and SalV strains are more closely related to the Morbillivirus-Respirovirus-Henipavirus subgroup and the Menanagle strain to the Rubulavirus-Avulavirus subgroup.
![]() View larger version (45K): [in a new window] |
FIG. 2. Amplification of RNAs from 25 different viral members in the subfamily Paramyxovirinae by one-step RT-PCR using the pan-PAR-F1/PAR-R primer pair (A) or the pan-PAR-F2/PAR-R primer pair (B). Viral names are abbreviated as shown in Table 1.
|
![]() View larger version (29K): [in a new window] |
FIG. 3. Amplification of RNAs from 14 different viral members in the genera of Henipavirus, Morbillivirus, and Respirovirus and two unclassified viral members in the subfamily Paramyxovirinae by one-step RT-PCR using the pan RES-MOR-HEN-F1/RES-MOR-HEN-R primer pair (A) or the pan RES-MOR-HEN-F2/RES-MOR-HEN-R primer pair (B). Each viral name is abbreviated as shown in Table 1.
|
![]() View larger version (46K): [in a new window] |
FIG. 4. Gel electrophoresis of amplification products of a one-step RT-PCR assay against RNA from eight different members of Avulavirus and Rubulavirus genera and one previously unclassified member of the subfamily Paramyxovirinae. The pan AVU-RUB-F1/AVU-RUB-R primer pair (A) or the pan AVU-RUB-F2/AVU-RUB-R primer pair (B) was used. Each virus gives an appropriately sized band and is identified by its abbreviation as shown in Table 1.
|
![]() View larger version (32K): [in a new window] |
FIG. 6. Gel electrophoresis of amplification products with subfamily and genus group seminested RT-PCR assays showing the appropriately sized positive band for the positive control material for the respective RT-PCR assay and no appropriately sized band for negative-control material or a pool of RNA from other common respiratory pathogens, as described in Materials and Methods. The seminested RT-PCR assays are pan-PAR (Paramyxovirinae subfamily), pan RES-MOR-HEN (group of Respirovirus, Morbillivirus, and Henipavirus genera), pan-AVU-RUB (group of Avulavirus and Rubulavirus genera), and pan-PNE (Pneumovirinae subfamily). Lanes: 1, positive control; 2, negative control (water); 3, blank; 4, pool of RNA from other common respiratory pathogens.
|
![]() View larger version (33K): [in a new window] |
FIG. 5. Gel electrophoresis of amplification products of one-step RT-PCR assays against RNA from seven different members of the subfamily Pneumovirinae. (A) Pan PNE-F1/PNE-R primer pair. (B) Pan PNE-F2/PNE-R primer pair. Each virus gives an appropriately sized band and is identified by its abbreviation as shown in Table 1.
|
![]() View larger version (44K): [in a new window] |
FIG. 7. Improved detection sensitivity by seminested RT-PCR and by genus subgroup primers with less degeneracy. (A) Seminested RT-PCR amplification of RNA extracted from 10-fold serial dilution of mumps virus stock using the pan-AVU-RUB-F1/AVU-RUB-R primer pair (1st run) and the pan-AVU-RUB-F2/AVU-RUB-R primer pair (2nd run). (B) Seminested RT-PCR amplification of RNA extracted from 10-fold serial dilution of mumps virus stock using the pan-PAR-F1/PAR-R primer pair (1st run) and the pan-PAR-F2/PAR-R primer pair (2nd run).
|
|
View this table: [in a new window] |
TABLE 3. Validation with clinical specimensa
|
|
|
|---|
The extensive variability within this family and the drop in sensitivity with increased primer degeneracy prevented us from developing a single assay for the family but instead led us to develop subfamily-specific and two genus subgroup PCR assays to achieve the desired level of sensitivity, <100 copies of RNA in the reaction mixture. The two genus subgroup assays took advantage of more closely related genera, i.e., a group of the Rubulavirus and Avulavirus genera and a group of the Morbillivirus, Respirovirus, and Henipavirus genera. The two genus subgroup assays reached the desired level of sensitivity, 10 and 100 copies, while the corresponding Paramyxovirinae subfamily assay achieved a sensitivity of 500 to 1,000 copies.
In summary, we have developed a set of seminested RT-PCR assays for detection of paramyxoviruses. The broad reactivity of these RT-PCR assays should allow us to detect known and novel members of the family Paramyxoviridae within genera described to date. The utility of these assays in discovery of novel members is supported by our ability to detect and classify eight recently isolated paramyxovirus species, Porpoise morbillivirus, Pacific salmon paramyxovirus, Bovine parainfluenza virus 1, Guinea pig parainfluenza virus 3, Canine parainfluenza virus 2, Canine parainfluenza virus 3, Menangle virus, and Salem virus, whose sequences were not available when the primers were designed. These pan-paramyxovirus PCR assays and similar assays for other viral families should enhance our ability to quickly identify, by virus family, subfamily, or genus, a wide range of novel viral pathogens and should enhance our ability to respond to and characterize outbreaks and diseases of unknown etiology.
Published ahead of print on 25 June 2008. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»